Revealed: 3 Stocks for Potentially Massive Gains
Here is the latest financial fact sheet of Wockhardt. For more details, see the Wockhardt quarterly results and Wockhardt share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 3.1 |
No. of shares | m | 110.04 |
% ch week | % | 1.7 |
% ch 1-mth | % | -8.2 |
% ch 12-mth | % | 83.0 |
52 week H/L | Rs | 569.8/211.0 |
No. of Mths Year Ending |
12 Mar-14* |
12 Mar-15* |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
5-Yr Chart Click to enlarge
|
---|
WOCKHARDT EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 2,070 | 1,980 | 2,000 | 1,129 | 1,012 | |
Low | Rs | 337 | 455 | 706 | 627 | 532 | |
Sales per share (Unadj.) | Rs | 440.1 | 407.2 | 403.0 | 363.1 | 355.9 | |
Earnings per share (Unadj.) | Rs | 76.6 | 36.8 | 22.8 | -20.4 | -60.3 | |
Diluted earnings per share | Rs | 76.4 | 36.8 | 22.9 | -20.5 | -60.6 | |
Cash flow per share (Unadj.) | Rs | 89.4 | 50.0 | 35.7 | -7.0 | -46.8 | |
Dividends per share (Unadj.) | Rs | 10.00 | 20.00 | 0 | 10.00 | 0.01 | |
Adj. dividends per share | Rs | 9.97 | 20.01 | 0.00 | 10.05 | 0.01 | |
Dividend yield (eoy) | % | 0.8 | 1.6 | 0 | 1.1 | 0 | |
Book value per share (Unadj.) | Rs | 299.1 | 335.1 | 341.6 | 301.8 | 257.8 | |
Adj. book value per share | Rs | 298.3 | 335.2 | 343.1 | 303.2 | 259.2 | |
Shares outstanding (eoy) | m | 109.75 | 110.07 | 110.51 | 110.55 | 110.63 | |
Bonus/Rights/Conversions | ESOP | ESOP | - | IS | - | ||
Price / Sales ratio | x | 2.7 | 3.0 | 3.4 | 2.4 | 2.2 | |
Avg P/E ratio | x | 15.7 | 33.1 | 59.3 | -42.9 | -12.8 | |
P/CF ratio (eoy) | x | 13.5 | 24.3 | 37.9 | -125.9 | -16.5 | |
Price / Book Value ratio | x | 4.0 | 3.6 | 4.0 | 2.9 | 3.0 | |
Dividend payout | % | 13.1 | 54.4 | 0 | -48.9 | 0 | |
Avg Mkt Cap | Rs m | 132,062 | 133,983 | 149,509 | 97,063 | 85,379 | |
No. of employees | `000 | 8.6 | 6.8 | 7.4 | 6.8 | 6.3 | |
Total wages/salary | Rs m | 7,686 | 8,689 | 9,508 | 9,665 | 9,371 | |
Avg. sales/employee | Rs Th | 5,616.7 | 6,557.7 | 6,037.2 | 5,931.8 | 6,295.0 | |
Avg. wages/employee | Rs Th | 893.8 | 1,271.4 | 1,289.0 | 1,428.1 | 1,498.3 | |
Avg. net profit/employee | Rs Th | 977.6 | 592.5 | 342.0 | -334.0 | -1,066.3 |
WOCKHARDT INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 48,304 | 44,815 | 44,530 | 40,146 | 39,369 | |
Other income | Rs m | 384 | 666 | 661 | 1,143 | 1,202 | |
Total revenues | Rs m | 48,688 | 45,481 | 45,191 | 41,289 | 40,571 | |
Gross profit | Rs m | 10,257 | 7,094 | 4,942 | 128 | 18 | |
Depreciation | Rs m | 1,399 | 1,454 | 1,419 | 1,489 | 1,495 | |
Interest | Rs m | 834 | 552 | 1,290 | 2,253 | 2,555 | |
Profit before tax | Rs m | 8,408 | 5,753 | 2,895 | -2,472 | -2,830 | |
Minority Interest | Rs m | -21 | -78 | 6 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 498 | 0 | 0 | 0 | -3,582 | |
Tax | Rs m | 479 | 1,627 | 379 | -211 | 257 | |
Profit after tax | Rs m | 8,407 | 4,049 | 2,522 | -2,260 | -6,669 | |
Gross profit margin | % | 21.2 | 15.8 | 11.1 | 0.3 | 0 | |
Effective tax rate | % | 5.7 | 28.3 | 13.1 | 8.5 | -9.1 | |
Net profit margin | % | 17.4 | 9.0 | 5.7 | -5.6 | -16.9 |
WOCKHARDT BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 33,559 | 34,637 | 39,519 | 45,353 | 33,796 | |
Current liabilities | Rs m | 17,432 | 17,752 | 18,419 | 19,788 | 26,917 | |
Net working cap to sales | % | 33.4 | 37.7 | 47.4 | 63.7 | 17.5 | |
Current ratio | x | 1.9 | 2.0 | 2.1 | 2.3 | 1.3 | |
Inventory Days | Days | 75 | 83 | 90 | 101 | 79 | |
Debtors Days | Days | 36 | 53 | 91 | 94 | 89 | |
Net fixed assets | Rs m | 30,022 | 33,909 | 37,369 | 40,165 | 39,664 | |
Share capital | Rs m | 549 | 550 | 553 | 553 | 553 | |
"Free" reserves | Rs m | 28,219 | 36,332 | 37,199 | 32,814 | 27,968 | |
Net worth | Rs m | 32,829 | 36,883 | 37,751 | 33,367 | 28,522 | |
Long term debt | Rs m | 11,023 | 14,270 | 19,206 | 31,903 | 21,731 | |
Total assets | Rs m | 66,220 | 71,715 | 81,209 | 90,217 | 81,620 | |
Interest coverage | x | 11.1 | 11.4 | 3.2 | -0.1 | -0.1 | |
Debt to equity ratio | x | 0.3 | 0.4 | 0.5 | 1.0 | 0.8 | |
Sales to assets ratio | x | 0.7 | 0.6 | 0.5 | 0.4 | 0.5 | |
Return on assets | % | 14.0 | 6.4 | 4.7 | 0 | -5.0 | |
Return on equity | % | 25.6 | 11.0 | 6.7 | -6.8 | -23.4 | |
Return on capital | % | 22.2 | 12.2 | 7.4 | -0.3 | -7.7 | |
Exports to sales | % | 12.8 | 10.0 | 11.6 | 0 | 0 | |
Imports to sales | % | 7.8 | 6.2 | 4.5 | 0 | 0 | |
Exports (fob) | Rs m | 6,180 | 4,471 | 5,177 | 0 | 0 | |
Imports (cif) | Rs m | 3,760 | 2,773 | 1,990 | 0 | 0 | |
Fx inflow | Rs m | 11,026 | 10,740 | 7,589 | 9,121 | 9,807 | |
Fx outflow | Rs m | 4,361 | 3,356 | 2,878 | 2,133 | 1,789 | |
Net fx | Rs m | 6,665 | 7,383 | 4,711 | 6,988 | 8,019 |
WOCKHARDT CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 14,763 | 3,550 | 716 | -2,695 | 684 | |
From Investments | Rs m | -8,516 | -2,066 | -8,182 | -6,866 | 6,302 | |
From Financial Activity | Rs m | -6,013 | -757 | 2,543 | 12,545 | -7,695 | |
Net Cashflow | Rs m | 234 | 727 | -4,941 | 3,007 | -664 |
Share Holding
|
Company Information
|
CHM: Habil Khorakiwala | COMP SEC: V. R. Khetan | YEAR OF INC: 1973 | BSE CODE: 532300 | FV (Rs): 5 | DIV YIELD (%): 0.0 |
More Pharmaceuticals Company Fact Sheets: ORCHID PHARMA LUPIN FDC SANOFI INDIA JUBILANT PHARMOVA
Compare WOCKHARDT With: ORCHID PHARMA LUPIN FDC SANOFI INDIA JUBILANT PHARMOVA
Compare WOCKHARDT With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US) TEVA PHARMA (Israel)
Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.
For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.
For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.
More Views on NewsRather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
What should you do if the market falls? In this video, I'll tell you what I will do.
A favourable demand supply scenario makes a strong case for real estate prices.
Ajit Dayal on how India's vaccine strategy will impact the markets.
Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market
More